No significant correlations were observed between age, sex, type of anti-VEGF, use or no use of anticoagulants, AMD subtype, symptom duration, DAs, baseline BCVA, CFT, thickness of the SMHs at the fovea, thickness of hemorrhagic PEDs at the fovea, and the changes in the BCVA (P > 0.05 for all comparisons). This evidence concerns the gene VEGFA and age-related macular degeneration.